270: Your guide to Wegovy’s blockbuster heart study
The Readout Loud
00:00
The Competition Between Novo and Lilly in the Diabetes Market
Jared: Does it surprise you that Novo and Lilly have such a significant lead on other pharmaceutical companies? Jared: It's important to remember that these products are essentially reformulations of drugs for diabetes. What I think is surprising is the speed at which this obesity market or the idea of this market has really come to fruition, he says.
Transcript
Play full episode
